Association between the baseline tumor size and outcomes of patients with non-small cell lung cancer treated with first-line immune checkpoint inhibitor monotherapy or in combination with chemotherapy.
Sign Up to like & getrecommendations! Published in 2022 at "Translational lung cancer research"
DOI: 10.21037/tlcr-21-815
Abstract: Background The baseline tumor size (BTS) is a prognostic factor for patients with non-small cell lung cancer (NSCLC) who received immune checkpoint inhibitor monotherapy (ICI-mono). However, this relationship is not yet known in patients treated… read more here.
Keywords: treated ici; max bts; ici mono; ici chemo ... See more keywords